ACT Brief: Who Sets Trial Endpoints, Human-Centered Trial Execution, and Bladder Cancer Approval Expansion

0:00-1:50

In today’s ACT Brief, we examine who decides what trials measure, how designing for human thinking improves site execution, and how the FDA extended an immunotherapy to a new bladder cancer population.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8965444

Published

October 16, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#setstrialendpoints #centeredtrialexecution #bladdercancerapproval #lifesciences

The Nile